Addressing Pneumococcal Disease in CKD Patients: A Call for Preventive Action Dr. Alan Almeida22 Jan 2025 11:49 AM ISTIn India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies reporting a prevalence...
Humanizing ICU Care: Role of Family Centred Care - Dr Himanshu Dewan Dr Himanshu Dewan4 Dec 2024 5:26 PM IST Development of advanced critical care units and intensive care medicine as a medical super speciality has had a massive impact on reducing...
Role of Cefepime/Enmetazobactam in Ventilator-associated Pneumonia (VAP) Dr. Kamal Kant Kohli4 Nov 2024 11:00 AM ISTKey Takeaways:Ventilator-associated pneumonia (VAP) is the most common ICU infection, affecting up to 20% of critically ill patients with a mortality...
Role of Cefepime Enmetazobactam in Complicated UTI Dr. Kamal Kant Kohli5 Sept 2024 11:08 AM ISTKey Messages:Treatment of complicated urinary tract infections (cUTIs) has become increasingly complex due to the rising incidences of antimicrobial...
Critical Care Review In 2023: Notable Achievements And Advancements - Dr Deepak V Dr Deepak V29 Dec 2023 11:10 AM ISTCritical care, once a nascent speciality, gained prominence when ICUs were inundated with COVID-19 patients in 2020. The demand for critical care...
Casirivimab/Imdevimab - An Indian Real World Experience : Review Dr. Kamal Kant Kohli10 Jun 2022 11:49 AM ISTThe antibody cocktail (Casirivimab and Imdevimab) has been approved in India for the treatment of mild to moderate COVID-19 in adolescents and adults...
Review: Efficacy of Antiviral Agents Against Omicron Subvariant BA.2 Dr. Kamal Kant Kohli16 May 2022 11:45 AM ISTThe omicron (B.1.1.529) variant of SARS-CoV-2, has spread rapidly around the world and has already become the predominant variant circulating in many...
Decoding REGEN-COV2 for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients Dr. Kamal Kant Kohli17 March 2022 11:45 AM ISTKidney transplant recipients are an immunocompromised population, with comorbid conditions such as obesity, diabetes, and coronary artery disease,...
Casirivimab and imdevimab in patients admitted to hospital with COVID-19: RECOVERY Trial Dr. Kamal Kant Kohli9 March 2022 5:19 PM ISTCasirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor-binding domain of the SARS-CoV-2...
Review: Antihypertensive Amlodipine for tackling circadian fluctuations of BP dr. Abhimanyu Uppal8 Feb 2022 11:22 AM ISTHypertension is the most powerful risk factor for cardiovascular diseases, including stroke, coronary artery disease, heart failure, chronic kidney...
Decoding safety, tolerability, and pharmacokinetics of Molnupiravir Dr. Kamal Kant Kohli4 Feb 2022 11:56 AM ISTMolnupiravir is a prodrug of active antiviral ribonucleoside analog b-D-N4-hydroxycytidine (NHC; EIDD-1931), with the potential to treat infections...
Quick Review: Effectiveness of REGEN-COV antibody cocktail against B.1.617.2 (delta) variant of SARS-CoV-2 Dr. Kamal Kant Kohli1 Feb 2022 12:34 PM ISTCasirivimab plus imdevimab antibody cocktail (REGEN-COV) has been shown to reduce viral load and prevent symptomatic disease in household contacts of...
